Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico

BMC Infectious Diseases

Carlos Alberto Guido-Arreola¹  Alma Rosa Pérez-Álamos³  Lucio Martínez-Ramírez¹  Sergio Estrada-Martínez³  Sandra Margarita Cerrillo-Soto¹  Agar Ramos-Nevárez¹  Luis Francisco Sánchez-Anguiano³  Jesús Hernández-Tinoco³  Cosme Alvarado-Esquivel² 

[1] Clínica de Medicina Familiar, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Predio Canoas S/N, 34079 Durango, Mexico;Biomedical Research Laboratory, Faculty of Medicine and Nutrition, Juárez University of Durango State, Avenida Universidad S/N, 34000 Durango, Mexico;Institute for Scientific Research “Dr. Roberto Rivera-Damm”, Juárez University of Durango State, Avenida Universidad S/N, 34000 Durango, Mexico

关键词: Mexico;    Epidemiology;    Infection;    Cytomegalovirus;    Seroprevalence;    Cross-sectional study;   

Others  :  1125649
DOI  :  10.1186/1471-2334-14-484

 received in 2014-07-05, accepted in 2014-09-03,  发布年份 2014

【 摘 要 】

Background

Cytomegalovirus causes congenital infections all around the world. The seroepidemiology of cytomegalovirus infection in pregnant women in Mexico is largely unknown. We sought to determine the seroprevalence of cytomegalovirus infection in pregnant women in Durango City, Mexico; and to determine seroprevalence association with socio-demographic, clinical and behavioral characteristics of pregnant women.

Methods

Through a cross-sectional study design, 343 pregnant women were examined for anti-cytomegalovirus IgG and IgM antibodies in Durango City, Mexico. We used a standardized questionnaire to obtain the general characteristics of the pregnant women. Multivariate analysis was performed to determine the association of cytomegalovirus infection with the characteristics of the pregnant women.

Results

Anti-CMV IgG and IgM antibodies were detected in 225 (65.6%) and in none of the 343 pregnant women studied, respectively. Multivariate analysis showed that CMV exposure was associated with increasing age (OR = 1.67; 95% CI: 1.01-2.76; P = 0.04). Other women characteristics including socioeconomic status, education, blood transfusion, transplantation, sexual promiscuity and number of previous pregnancies or deliveries did not show an association with CMV exposure.

Conclusions

This is the first seroepidemiology study of CMV infection in pregnant women in Mexico. A number of known factors associated with CMV infection were not associated with CMV exposure in the women studied. Further studies to determine routes of CMV infection in pregnant women in Mexico are needed.

【 授权许可】

   
2014 Alvarado-Esquivel et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA: Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998, 39:141-162.
• [2]Hyde TB, Schmid DS, Cannon MJ: Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010, 20:311-326. doi:10.1002/rmv.659
• [3]Kenneson A, Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
• [4]Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK: The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013, 26:86-102. doi:10.1128/CMR.00062-12
• [5]Buonsenso D, Serranti D, Gargiullo L, Ceccarelli M, Ranno O, Valentini P: Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci 2012, 16:919-935.
• [6]Swanson EC, Schleiss MR: Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am 2013, 60:335-349. doi:10.1016/j.pcl.2012.12.008
• [7]Goodrum F, Caviness K, Zagallo P: Human cytomegalovirus persistence. Cell Microbiol 2012, 14:644-655. doi:10.1111/j.1462-5822.2012.01774.x
• [8]Cannon MJ, Schmid DS, Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20:202-213. doi:10.1002/rmv.655
• [9]Lindholm PF, Annen K, Ramsey G: Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets 2011, 11:45-56.
• [10]Foti G, Hyeraci M, Kunkar A, Ieropoli G, Sofo D, De Lorenzo S, Carpentieri MS: Cytomegalovirus infection in the adult. Minerva Med 2002, 93:109-117.
• [11]Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E: Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine 2013, 31:5067-5074. doi:10.1016/j.vaccine.2013.08.077
• [12]Echániz-Avilés G, Tamayo-Legorreta E, Cruz-Valdez A, Rangel-Flores H, Hernández-Nevárez P, Gatica-Marquina R, Calderón-Jaimes E: Prevalence of antibodies against cytomegalovirus in women of reproductive age. Salud Publica Mex 1993, 35:20-26.
• [13]Wujcicka W, Gaj Z, Wilczyński J, Sobala W, Spiewak E, Nowakowska D: Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis 2014. in press
• [14]Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, Sago H, Kozuka K: Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol 2014, 59:192-194. doi:10.1016/j.jcv.2013.12.013
• [15]Barlinn R, Vainio K, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG: Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol 2014, 86:820-826. doi:10.1002/jmv.23757
• [16]Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ: Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One 2013, 8:e81881. doi:10.1371/journal.pone.0081881
• [17]Enders G, Daiminger A, Lindemann L, Knotek F, Bäder U, Exler S, Enders M: Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol 2012, 201:303-309. doi:10.1007/s00430-012-0232-7
• [18]Erfanianahmadpoor M, Nasiri R, Vakili R, Hassannia T: Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J 2014, 35:360-364.
• [19]Neirukh T, Qaisi A, Saleh N, Rmaileh AA, Zahriyeh EA, Qurei L, Dajani F, Nusseibeh T, Khamash H, Baraghithi S, Azzeh M: Seroprevalence of cytomegalovirus among pregnant women and hospitalized children in Palestine. BMC Infect Dis 2013, 13:528. doi:10.1186/1471-2334-13-528 BioMed Central Full Text
• [20]Yamamoto AY, Castellucci RA, Aragon DC, Mussi-Pinhata MM: Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol Infect 2013, 141:2187-2191. doi:10.1017/S0950268812002695
• [21]Uysal A, Taner CE, Cüce M, Atalay S, Göl B, Köse S, Uysal F: Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet 2012, 286:605-608. doi:10.1007/s00404-012-2353-z
• [22]Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA, Adediran A, Osunkalu VO: Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Womens Health 2011, 3:423-428. doi:10.2147/IJWH.S24850
• [23]Correa CB, Kourí V, Verdasquera D, Martínez PA, Alvarez A, Alemán Y, Pérez L, Viera J, González R, Pérez E, Moro I, Navarro MA, Melin P: HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn 2010, 30:888-892. doi:10.1002/pd.2587
• [24]Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 2006, 43:1143-1151.
• [25]Raynor BD: Cytomegalovirus infection in pregnancy. Semin Perinatol 1993, 17:394-402.
• [26]Johnson J, Anderson B, Pass RF: Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 2012, 55:521-530. doi:10.1097/GRF.0b013e3182510b7b
• [27]Cannon MJ, Hyde TB, Schmid DS: Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011, 21:240-255. doi:10.1002/rmv.695